CBE ID
2525
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Fall 2025
1.6 Measure Description
Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis who are newly prescribed disease modifying anti-rheumatic drug (DMARD) therapy within 12 months.
Measure Specs
General Information
1.7 Measure Type
1.3 Electronic Clinical Quality Measure (eCQM)
1.8 Level of Analysis
Numerator
1.14 Numerator
Patient received a DMARD
Denominator
1.15 Denominator
Patient age 18 years and older with a diagnosis of rheumatoid arthritis seen for two or more face-to-face encounters for RA with the same clinician during the measurement period
Exclusions
Exclusions
Patients with a diagnosis of HIV; patients who are pregnant; or patients with inactive Rheumatoid Arthritis.
Measure Record
Most Recent Endorsement Activity
Approved for Trial Use Primary Care and Chronic Illness Spring Cycle 2019
Initial Endorsement
Last Updated
Point of Contact
Steward Organization
American College of Rheumatology
Steward POC email
RMYSLINSKI@RHEUMATOLOGY.ORG
Steward Organization Copyright
Copyright (c) 2013, American College of Rheumatology
Importance
Equity
Feasibility
Scientific Acceptability
Risk Adjustment
Risk Adjustment
Use & Usability
Use
6.1.2 Current or Planned Use(s)
Public Comments